Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software
solutions and designer of Myrian®, hereby sets out its ambitions, development
plan and financial publication timetable for 2022.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software
solutions and the medical imaging and radiology group I-SERIS, which includes
the clinics of Clémentville (Montpellier), Clermont l'Hérault and the scanner center
of the Pasteur clinic in Pézenas, announce the signing of an agreement for the
development of the new oncology solution Myra.

Intrasense announces its 2021 consolidated IFRS half-year results at Group level as of June 30, 2021.

Intrasense is pleased to announce its participation in the congress of the Société d'Imagerie de la Femme, in Ajaccio from September 17 to 19.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software
solutions and Myrian® designer provides an update on its development strategy
following its successful capital increase in June 2021.

Intrasense today announced the success of its capital increase through the issuance of new shares (“New Shares”) with shareholders’ preferential subscription rights, for which subscriptions took place between May 28 and June 15, 2021 (the “Rights Issue”).

Intrasense launch a capital increase through the issuance of new shares with shareholders’ preferential subscription rights. 

Intrasense today announces the publication of its annual financial report for the financial year ended on December 31, 2020.

Intrasense and Vidi, the leading cooperative network of medical imaging groups in France, signed an agreement on January 30th, 2021 to reference Myrian® solutions.

Intrasense is pleased to present the new version 2.9, with a focus on new clinical features.